Pfizer Unveils Positive Results for VIZIMPRO® as first-line monotherapy in NSCLC patients

Singapore |  News | 0 Comment | 26 Nov, 2019

Pfizer Inc. on 25th Nov 2019, announced the efficacy and tolerability results from the subgroup analysis of Asian patients enrolled in the  ARCHER 1050, a randomized, multicenter, mult...Read more

Merck presented Data on Tepotinib for NSCLC at ESMO Asia 2019

Singapore |  News | 0 Comment | 25 Nov, 2019

Merck, a leading science and technology company, on 25 Nov 2019, announced the presentation of multiple abstracts on tepotinib* at the European Society for Medical Oncology (ESMO) Asia Cong...Read more

5th ESMO Asia Congress highlights Asia’s increasing Cancer Burden

Singapore |  News | 0 Comment | 25 Nov, 2019

The ESMO Asia Congress 2019 came to a close on 24th Nov 2019, after three days of thought-provoking lectures aimed at shaping the future of cancer care and keeping the regional on...Read more

Flu vaccination lessen the preventable burden of flu in diabetics

Singapore |  News | 0 Comment | 25 Nov, 2019

A team of researchers at Singapore on 22 Nov 2019 revealed the need for improved flu protection amongst those living with diabetes. In vulnerable populations such as people living with diab...Read more

Singapore to establish Smart Digital and Multiplex Path lab

Singapore |  News | 0 Comment | 26 Nov, 2019

A!maginostic (A!), an A*STAR spin-off that specialises in computational digital pathology, and A*STAR’s Institute of Molecular and Cell Biology (IMCB) have la...Read more

ESMO Asia Congress 2019: Explores Advances in cancer prevention, treatment and care

Singapore |  News | 0 Comment | 22 Nov, 2019

The ESMO Asia Congress returned for its fifth edition at the Suntec Singapore Convention & Exhibition Centre, on 22nd to 24th Nov 2019, bringing together over 3,500 medical professional...Read more

Combination of Immunotherapy and VEGF Inhibitor Improves Survival in HCC

Singapore |  News | 0 Comment | 22 Nov, 2019

Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresecta...Read more

Trastuzumab Biosimilar HLX02 Met Primary Endpoint in Breast Cancer

Singapore |  News | 0 Comment | 22 Nov, 2019

The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epidermal growth factor receptor 2-positive (HER2+) recurrent or previou...Read more

Singapore makes progress in war against diabetes

Singapore |  News | 0 Comment | 22 Nov, 2019

The Ministry of Health (MOH) in Singapore has released a summary report highlighting the key initiatives and progress made on the War of Diabetes (WoD) over the past three years in addressi...Read more

Medtech startup Eko.ai clinches Startup SG's SLINGSHOT 2019 top prize

Singapore |  News | 0 Comment | 15 Nov, 2019

Eko.ai was awarded the Startup SG grand prize of S$250,000 Startup SG grant at SLINGSHOT 2019 powered by Startup SG, organised by Enterprise Singapore. The competition, held in Singapore on...Read more

PMR launches report on "Secure Messaging in Healthcare Market"

Singapore |  News | 0 Comment | 21 Nov, 2019

Secure messaging in healthcare is set to become a billion-dollar market by 2029, as indicated by a new research study. Witnessing stupendous expansion at a CAGR of 20% during the forecast p...Read more

Chronic Stress-related Illness is the Largest Health Expenditure facing Health Systems

Singapore |  News | 0 Comment | 21 Nov, 2019

The impact of stress-related conditions on Singapore’s health system conservatively equates to US$2.3 billion of spend (approx. S$3.18 billion) or 18% of health expenditure according ...Read more

Singapore’s Inaugural SFF x SWITCH sees over 60,000 participants from 140 countries

Singapore |  News | 0 Comment | 19 Nov, 2019

The Singapore FinTech Festival (SFF) and the Singapore Week of Innovation and TeCHnology (SWITCH) concluded its combined week-long event on 15 November 2019, which attracted more than 60,00...Read more

Duke-NUS introduces Clinical Sciences PhD programme in translational research

Singapore |  News | 0 Comment | 21 Nov, 2019

Duke-NUS Medical School’s PhD programme in Clinical Sciences (PhD CS) addresses an important need in the field, by being the first PhD programme in Singapore and Southeast Asia to spe...Read more

Biofourmis announces acquisition of Biovotion AG

Singapore |  News | 0 Comment | 19 Nov, 2019

Biofourmis has announced that it has reached an agreement to acquire Zürich, Switzerland-based Biovotion AG, developer of clinical-grade wearable biosensor platform. The acquisition in...Read more

Biofourmis collaborates with Novartis for patients with heart failure

Singapore |  News | 0 Comment | 19 Nov, 2019

Singapore founded Biofourmis, global leader in digital therapeutics based in Boston, announced that it has been selected by Novartis, a global healthcare company, to collaborate on a commer...Read more

Novotech wins 2019 APAC Biotech CRO award

Singapore |  News | 0 Comment | 19 Nov, 2019

Novotech, the Asia-Pacific CRO, has again won the prestigious Asia-Pacific CRO of the year awarded by leading analyst firm Frost & Sullivan. This is the fifth year Novotech has been awa...Read more

NTU makes novel discovery in diabetes research

Singapore |  News | 0 Comment | 20 Nov, 2019

Nanyang Technological University, Singapore (NTU Singapore) scientists have discovered that a type of immune cell known as ‘pancreatic islet macrophages’ is capable of promoti...Read more